Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Potently Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection
Wafaa B. Alsoussi, Jackson S. Turner, James Brett Case, et al.
The Journal of Immunology (2020) Vol. 205, Iss. 4, pp. 915-922
Open Access | Times Cited: 209

Showing 1-25 of 209 citing articles:

SARS-CoV-2 vaccines in development
Florian Krammer
Nature (2020) Vol. 586, Iss. 7830, pp. 516-527
Open Access | Times Cited: 2058
Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology
Luca Piccoli, Young‐Jun Park, M. Alejandra Tortorici, et al.
Cell (2020) Vol. 183, Iss. 4, pp. 1024-1042.e21
Open Access | Times Cited: 1438
Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies
Allison J. Greaney, Andrea N. Loes, Katharine H. D. Crawford, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 3, pp. 463-476.e6
Open Access | Times Cited: 1215
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition
Allison J. Greaney, Tyler N. Starr, Pavlo Gilchuk, et al.
Cell Host & Microbe (2020) Vol. 29, Iss. 1, pp. 44-57.e9
Open Access | Times Cited: 1062
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
Rita E. Chen, Xianwen Zhang, James Brett Case, et al.
Nature Medicine (2021) Vol. 27, Iss. 4, pp. 717-726
Open Access | Times Cited: 970
Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization
Zhuoming Liu, Laura A. VanBlargan, Louis-Marie Bloyet, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 3, pp. 477-488.e4
Open Access | Times Cited: 809
Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19
Lauren B. Rodda, Jason Netland, Laila Shehata, et al.
Cell (2020) Vol. 184, Iss. 1, pp. 169-183.e17
Open Access | Times Cited: 670
De novo design of picomolar SARS-CoV-2 miniprotein inhibitors
Longxing Cao, Inna Goreshnik, Brian Coventry, et al.
Science (2020) Vol. 370, Iss. 6515, pp. 426-431
Open Access | Times Cited: 594
Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms
M. Alejandra Tortorici, Martina Beltramello, Florian A. Lempp, et al.
Science (2020) Vol. 370, Iss. 6519, pp. 950-957
Open Access | Times Cited: 582
A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2
Ahmed O. Hassan, Natasha M. Kafai, Igor P. Dmitriev, et al.
Cell (2020) Vol. 183, Iss. 1, pp. 169-184.e13
Open Access | Times Cited: 529
SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans
Jackson S. Turner, Wooseob Kim, Elizaveta Kalaidina, et al.
Nature (2021) Vol. 595, Iss. 7867, pp. 421-425
Open Access | Times Cited: 515
Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2
Alexandra C. Walls, Brooke Fiala, Alexandra Schäfer, et al.
Cell (2020) Vol. 183, Iss. 5, pp. 1367-1382.e17
Open Access | Times Cited: 497
Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein
Naveenchandra Suryadevara, Swathi Shrihari, Pavlo Gilchuk, et al.
Cell (2021) Vol. 184, Iss. 9, pp. 2316-2331.e15
Open Access | Times Cited: 382
Tackling COVID-19 with neutralizing monoclonal antibodies
Davide Corti, Lisa A. Purcell, Gyorgy Snell, et al.
Cell (2021) Vol. 184, Iss. 12, pp. 3086-3108
Open Access | Times Cited: 369
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection
Emma S. Winkler, Pavlo Gilchuk, Jinsheng Yu, et al.
Cell (2021) Vol. 184, Iss. 7, pp. 1804-1820.e16
Open Access | Times Cited: 349
Heterogeneity of meningeal B cells reveals a lymphopoietic niche at the CNS borders
Simone Brioschi, Wei-Le Wang, Vincent Peng, et al.
Science (2021) Vol. 373, Iss. 6553
Open Access | Times Cited: 318
SARS-CoV-2, COVID-19 and the aging immune system
Juliet M. Bartleson, Dina Radenković, Anthony J. Covarrubias, et al.
Nature Aging (2021) Vol. 1, Iss. 9, pp. 769-782
Open Access | Times Cited: 277
COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants
Pinja Jalkanen, Pekka Kolehmainen, Hanni K. Häkkinen, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 270
In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains
Rita E. Chen, Emma S. Winkler, James Brett Case, et al.
Nature (2021) Vol. 596, Iss. 7870, pp. 103-108
Open Access | Times Cited: 251
A human coronavirus evolves antigenically to escape antibody immunity
Rachel Eguia, Katharine H. D. Crawford, Terry Stevens-Ayers, et al.
PLoS Pathogens (2021) Vol. 17, Iss. 4, pp. e1009453-e1009453
Open Access | Times Cited: 221
Extremely potent human monoclonal antibodies from COVID-19 convalescent patients
Emanuele Andreano, Emanuele Nicastri, Ida Paciello, et al.
Cell (2021) Vol. 184, Iss. 7, pp. 1821-1835.e16
Open Access | Times Cited: 219
SARS-CoV-2 spreads through cell-to-cell transmission
Cong Zeng, John P. Evans, Tiffany King, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 119, Iss. 1
Open Access | Times Cited: 201
Comprehensive mapping of mutations to the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human serum antibodies
Allison J. Greaney, Andrea N. Loes, Katharine H. D. Crawford, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 199
De novo design of potent and resilient hACE2 decoys to neutralize SARS-CoV-2
Thomas W. Linsky, Renan Vergara, N. Codina-Castillo, et al.
Science (2020) Vol. 370, Iss. 6521, pp. 1208-1214
Open Access | Times Cited: 198
Structural basis for broad coronavirus neutralization
Maximilian M. Sauer, M. Alejandra Tortorici, Young‐Jun Park, et al.
Nature Structural & Molecular Biology (2021) Vol. 28, Iss. 6, pp. 478-486
Open Access | Times Cited: 195
Page 1 - Next Page

Scroll to top